Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/2/13 → 8/29/18 |
Funding
- BioMarin Pharmaceutical Inc. (111-202)
111-202: A Phase 2, Open-label, Sequential Cohort Dose-escalation Study of BMN 111 in Children with Achondroplasia
- Charrow, Joel (PD/PI)
- Burton, Barbara K (Co-Investigator)
Project: Research project